Below are the most recent publications written about "HIV Infections" by people in Profiles.
-
Dong L, Bogart LM, Vincent T, Adekunle T, Gilbert M, Bai J, Miller P, Huilgol S, Ojikutu BO. An HIV care provider training on addressing intersectional stigma and medical mistrust: A pilot randomized controlled trial. Patient Educ Couns. 2026 Aug; 149:109678.
-
Nnaji C, Patel RC, Adigwe AO, Day PG, Escobar MF. A Community-Based, Multidisciplinary Training Program to Improve HIV Services for US-Based African Immigrants: Lessons Learned over 5 Years of Implementation. Int J Environ Res Public Health. 2026 Mar 06; 23(3).
-
Castelli JMP, Poljakov K, Jwa Y, Cunningham R, Cassidy ME, Gray MD, Sanchez Gaytan JN, Enstrom MR, Gastelum G, Wang Z, Linton JD, Rongvaux A, Taylor JJ, Adair JE. In vivo production of an anti-HIV antibody in mice by non-viral gene knockin in primate hematopoietic stem and progenitor cells. Mol Ther. 2026 May 06; 34(5):2754-2769.
-
Bovell-Ammon BJ, Onofrey S, Kimmel SD, Wurcel AG, Klevens RM. Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study. BMC Public Health. 2026 Jan 30; 26(1).
-
Kelley CF, Weddle A, Agwu A, Bolduc PJ, Person AK. Persistence Is Resistance: The Fight to End the HIV Epidemic Hangs in the Balance. J Infect Dis. 2026 Jan 17; 233(1):6-8.
-
D?az-Salinas MA, Benlarbi M, Chatterjee D, Nayrac M, Robidas M, Pinyakorn S, Phanuphak N, Sacdalan C, Medjahed H, Pr?vost J, Trautmann L, Pazgier M, Finzi A, Munro JB. Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicity. J Virol. 2026 01 20; 100(1):e0166725.
-
Torre P, Sirag E, Williams PL, Zhang Z, Frederick T, Purswani M, Hoffman HJ, Yao TJ. Hearing Measures in Children Perinatally HIV-exposed and Uninfected in the PHACS SMARTT Study. Pediatr Infect Dis J. 2026 Jun 01; 45(6):498-504.
-
Tao J, Luo Q, Haas CB, Mbulaiteye SM, Hayes J, Cohen C, Pawlish KS, Cherala S, Engels EA, Morton LM, Shiels MS. Risk of lymphoma among people with HIV in the United States, 2001-2019. J Natl Cancer Inst. 2025 Dec 01; 117(12):2505-2512.
-
Go VF, Giang LM, Phan HTT, Chen JS, Powell BJ, Bartels SM, Nguyen MXB, Sripaipan T, Nong HTT, Dang LTH, Pham MD, Vo SH, Tran HV, Hoang VTH, Nguyen NTK, Chu AV, Levintow SN, Dowdy DW, Sohn H, Pence BW, Miller WC. Scaling an intervention for the engagement of people with HIV who inject drugs into care in Viet Nam: an implementation-effectiveness, cluster-randomised trial. Lancet Glob Health. 2025 Dec; 13(12):e2111-e2121.
-
Richard J, Grunst MW, Niu L, D?az-Salinas MA, Zhu L, Tolbert WD, Marchitto L, Zhou F, Bourassa C, Kim H, Boodapati SLT, Yang D, Chiu TJ, Chen HC, Benlarbi M, Beaudoin-Bussi?res G, Gottumukkala S, Li W, Dionne K, B?langer ?, Chatterjee D, Medjahed H, Hendrickson WA, Sodroski J, Lang ZC, Morton AJ, Huang RK, Matthies D, Smith AB, Kumar P, Mothes W, Munro JB, Pazgier M, Finzi A. The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC. Nat Commun. 2025 Dec 01; 16(1):10419.